Category Archives: healthcare
By Pharm Exec | Published: June 13, 2014
The future of GSK’s Tykerb (lapatinib) in the breast cancer market is unclear, after the combination of Tykerb and Herceptin in the large Phase III trial, ALTTO, showed no statistical superiority over Herceptin alone for improving disease-free survival, says research and consulting firm GlobalData.
By Julian Upton | Published: June 12, 2014
They say the road to hell is paved with good intentions. The row in the UK over NICE’s call to doctors to increase the use of statins looked to be good example of this handy aphorism. That was until things took a potentially darker turn.
By Guest Blogger | Published: June 11, 2014
by Tom Norton Years ago, while sitting in an Rx company lunch room, I was listening to one of the company’s top sales reps discuss the commercial progress a recently launched prescription was making. The rep said that the product was selling “OK” under its FDA approved, indicated therapeutic area. However, he quietly said, “It’s […]
By Guest Blogger | Published: June 10, 2014
By Bill Drummy, Pharm Exec Editorial Advisory Board. Among the many announcements Apple made earlier this month at its annual World Wide Developer’s Conference, one was of particular interest to the healthcare industry. Apple unveiled “HealthKit”, which is really a developer’s toolbox that allows makers of health and medical devices (e.g. Fitbit, UP, Misfit, iHealth) to […]
By Guest Blogger | Published: June 6, 2014
By Michael Winter, Egon Zehnder. Consumer health, the business of selling health and wellness sustaining-brands in categories as diverse as pain relievers, brain-boosting yogurts, sports nutrition, baby food and bone supplement drinks, is poised to take off globally. With consumers becoming ever more health-aware and knowledgeable, companies from both the pharma and consumer segments are […]